
Product Use: Beconase is used for prophylaxis and the short-term treatment of perennial and seasonal allergic rhinitis
Classification: OTC Pharmacy Only Medicine (No Prescription Required)
Manufacturer: GlaxoSmithKline
| NZD | $29.70 |
Beconase is used for prophylaxis and the short-term treatment of perennial and seasonal allergic rhinitis including hayfever, and vasomotor rhinitis. It works by reducing swelling and inflammation in the nose.
Adults and Children over 12 years of age: The recommended dose is two sprays into each nostril twice daily. Once control has been established, it may be possible to maintain control with fewer sprays. A dosage regimen of one spray into each nostril morning and evening has been shown to be efficacious in some patients. However, should the symptoms recur, patients should revert to the recommended dosage of two sprays into each nostril morning and evening. Total daily administration should not normally exceed 400mcg. For full therapeutic benefit regular usage is essential as beconase controls the underlying disorders responsible for hayfever attacks. Beconase starts to work immediately, but may take 2-3 days to build up to its maximum protective effect. The minimum dose should be used at which effective control of symptoms is maintained.
Children under twelve years old: There is insufficient clinical data to recommend use.
Beclomethasone Dipropionate 50mcg per actuation. Each bottle delivers an accurate measured spray. A bottle contains 200 sprays. Each spray contains 50 micrograms of beclomethasone dipropionate in a liquid. The liquid also contains dextrose, Avicel, phenylethyl alcohol, benzalkonium chloride and polysorbate 80.
You should consult your doctor before using beconase nasal spray if:
